NCT04912050已完成不适用
EXtension of Tablo TrEatmeNt Duration Registry (XTEND)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 33
- 试验地点
- 1
- 主要终点
- Treatment Success
研究概览
简要总结
Observational, retrospective and prospective, multicenter, post-market study of the Tablo Hemodialysis System in hospitalized participants with End-Stage Kidney Disease or Acute Kidney Injury who are prescribed renal replacement therapy > 12 hours.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participant weighs ≥ 34kg.
- •Participant is hospitalized and has dialysis dependent End-Stage Kidney Disease or Acute Kidney Injury and is prescribed renal replacement therapy > 12 hours.
排除标准
- •Any documented condition that the Physician feels would prevent the participant from successful inclusion in the study.
结局指标
主要结局
Treatment Success
时间窗: Up to 24 hours
Percentage of treatments achieving prescribed dialysis treatment time ≤ 10%
次要结局
- Tablo Cartridge Life(up to 24 hours)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)Short Bowel SyndromeNCT00930644Shire88
终止
3 期
Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642)Cystic FibrosisNCT00846781Merck Sharp & Dohme LLC308
已完成
3 期
A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302Short Bowel SyndromeNCT03268811Shire9
进行中（未招募）
2 期
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeCushing SyndromeNCT03604198Corcept Therapeutics125
已完成
3 期
Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 DiabetesType 2 DiabetesNCT00151762Daiichi Sankyo780